Loss And Gain: Trade War Halves China Biotech VC Funding To US, But Asian Countries May Benefit

Chinese venture funding to the US biotech sector has fallen by nearly 60% in the latest sign of cooling in the previously booming bilateral life sciences investment sector.

Money Wave
CHINA VC FUNDING TO US BIOTECH DROPS BY MORE THAN HALF IN 2019 1H • Source: Shutterstock

More from China

More from Focus On Asia